Addus HomeCare (NASDAQ:ADUS) CEO R Dirk Allison Sells 4,988 Shares

Addus HomeCare Corporation (NASDAQ:ADUS) CEO R Dirk Allison sold 4,988 shares of the stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total value of $533,616.24. Following the completion of the sale, the chief executive officer directly owned 185,514 shares of the company’s stock, valued at approximately $19,846,287.72. The trade was a 2.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

R Dirk Allison also recently made the following trade(s):

• On Wednesday, February 25th, R Dirk Allison sold 2,364 shares of Addus HomeCare stock. The stock was sold at an average price of $105.36, for a total value of $249,071.04.

Addus HomeCare Trading Down 3.3%

NASDAQ:ADUS traded down $3.58 on Thursday, reaching $104.02. 269,378 shares of the stock traded hands, compared to its average volume of 239,147. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $124.43. The company’s 50 day moving average is $109.57 and its 200-day moving average is $113.08. The firm has a market capitalization of $1.92 billion, a price-to-earnings ratio of 19.97, a price-to-earnings-growth ratio of 1.26 and a beta of 0.91.

Addus HomeCare News Roundup

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&A-driven growth strategy for 2026 — supports longer?term earnings upside. Addus HomeCare Earnings Call Highlights Growth And Scale
• Positive Sentiment: Stephens trimmed its price target from $140 to $135 but kept an “overweight” rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. Stephens price target note
• Neutral Sentiment: Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). Conference participation
• Neutral Sentiment: Some published short?interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. MarketBeat ADUS page
• Negative Sentiment: Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre?planned. See CEO filing. CEO insider-sale SEC filing
• Negative Sentiment: Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days?to?cover) — elevated short activity can amplify downward price moves. Short interest data

Analysts Set New Price Targets

A number of analysts have commented on the stock. Truist Financial set a $135.00 price target on shares of Addus HomeCare and gave the company a “buy” rating in a research report on Wednesday, January 7th. Wall Street Zen upgraded Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research report on Monday. Barclays decreased their target price on Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating for the company in a research note on Tuesday. TD Cowen reissued a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. Finally, BMO Capital Markets began coverage on Addus HomeCare in a report on Thursday, November 13th. They set a “market perform” rating and a $120.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $134.33.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds have recently added to or reduced their stakes in the company. Capital Research Global Investors raised its position in shares of Addus HomeCare by 22.3% during the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after purchasing an additional 268,192 shares during the period. Tributary Capital Management LLC increased its stake in Addus HomeCare by 114.1% during the 3rd quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock valued at $46,974,000 after purchasing an additional 212,192 shares in the last quarter. Freestone Grove Partners LP raised its holdings in Addus HomeCare by 5,035.2% during the fourth quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock worth $14,813,000 after buying an additional 135,246 shares during the last quarter. 8 Knots Management LLC bought a new position in shares of Addus HomeCare in the third quarter valued at $6,075,000. Finally, TimesSquare Capital Management LLC grew its holdings in shares of Addus HomeCare by 13.9% during the second quarter. TimesSquare Capital Management LLC now owns 394,047 shares of the company’s stock valued at $45,390,000 after buying an additional 48,207 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.